Abstract
Particularly designed for ultra-sensitive early-stage cancer detection, this ground-breaking study offers a novel fusion of
photonic crystal fiber (PCF) technology with surface plasmon resonance (SPR) sensing systems. A unique hexagonal lattice
PCF structure with ideal air hole geometry and judicious gold nanoparticle implantation is included into the created biosensor
to attain hitherto unheard-of sensitivity in cancer biomarker detection. With a resolution of 2.1×10^-5 RIU, the sensor shows
impressive performance metrics by means of rigorous computational analysis and experimental validation: a sensitivity of
4,235 nm/RIU in the key refractive index range of 1.33–1.34. By allowing simultaneous detection of several cancer
biomarkers—including Carcino embryonic Antigen (CEA), Alpha-fetoprotein (AFP), and Cancer Antigen 125 (CA-125)—the
sensor architecture achieves detection limits as low as 0.085 ng/mL in complicated biological matrices. Further improving the
sensor's dependability and sensitivity is the use of sophisticated signal processing algorithms with machine learning methods.
With a sensitivity of 98.7% and a specificity of 99.2%, thorough clinical validation employing 1,500 patient samples shows the
sensor's strong performance in real-world diagnostic settings. This work marks a major progress in the creation of easily
available, very sensitive, and reasonably priced diagnostic instruments for early cancer detection, hence transforming pointof-care cancer diagnosis and monitoring.
Keywords
Photonic crystal fiber, Surface plasmon resonance, Cancer biomarkers, Nanophotonic biosensor, Early cancer detection,
Plasmonic enhancement.
Citation
GAUTAM NARAYAN NIRALA, SIMARPREET KAUR, SHAHIRUDDIN, P. R. YASHASWINI, M. A. IBRAR JAHAN, Photonic crystal based finer surface plasmonic sensor for detecting cancer, Optoelectronics and Advanced Materials - Rapid Communications, 19, 5-6, May-June 2025, pp.251-262 (2025).
Submitted at: Jan. 30, 2025
Accepted at: June 3, 2025